TP53 and hepatocellular carcinoma: As p53 is frequently mutated or lost in human HCC and p53 is actively involved in metastasis via regulation on β-catenin signaling as shown in this study, we postulate that inhibition of β-catenin pathway would be an effective therapeutic strategy to control metastasis of human HCC.